Key facts
- This page summarizes Steve E. Krognes's Form 4 filing for Guardant Health, Inc. (GH).
- 4 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 13 Jun 2024, 20:56.
Steve E. Krognes - 12 Jun 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- Director
- Issuer ticker
- GH
- Reported as of
- 12 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Jun 2024, 20:56:35 UTC
- Prior SEC filing
- 03 Jun 2024
- Next SEC filing
- 17 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Saia, as attorney-in-fact for Steve Krognes
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve E. Krognes filed Form 4 for Guardant Health, Inc. (GH) on 13 Jun 2024.
Change
- Previous filing in this sequence was filed on 03 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +5,592
- Change %
- +158%
- Price
- $0.000000
- Shares after
- 9,140
- Date
- 12 Jun 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -5,592
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,592
- Exercise price
- $0.000000
- Footnotes
- F1, F2
GH
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +10,703
- Change %
- Price
- $0.000000
- Shares after
- 10,703
- Date
- 12 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,703
- Exercise price
- $31.84
- Footnotes
- F3
GH
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +6,674
- Change %
- Price
- $0.000000
- Shares after
- 6,674
- Date
- 12 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,674
- Exercise price
- $0.000000
- Footnotes
- F2, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.
Footnote F2
Not applicable for Restricted Stock Units.
Footnote F3
The stock option vests in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier.
Footnote F4
The restricted stock units vest in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier.